Pharmafile Logo

KOL Strategy

- PMLiVE

EU secures 405 million doses of CureVac’s COVID-19 vaccine

CureVac revealed early stage data for its vaccine earlier this month

- PMLiVE

J&J advances COVID-19 vaccine into second phase 3 trial

ENSEMBLE study will enrol 60,000 people worldwide

- PMLiVE

Moderna’s COVID-19 vaccine is 94.5% effective, initial data suggests

The UK government has secured access to five million doses of the vaccine

- PMLiVE

Synairgen’s SNG001 advances into phase 3 COVID-19 trial

UK biotech had initially been testing drug for COPD and asthma

- PMLiVE

Sobi’s Gamifant receives final rejection from CHMP for primary HLH

Committee reiterated previous negative opinion

- PMLiVE

UCB boosts gene therapy offering with a pair of new deals

Company will collaborate with Lacerta Therapeutics and acquire Handl Therapeutics

- PMLiVE

Great creative is effective creative. And effective creative is affective creative

Our creative approach at Fishawack Health is Affective Creativity. Creative crafted to make deep, motivating connections with our target audience. We tap into psychology and combine that with creative craft...

Blue Latitude Health

- PMLiVE

CureVac says its COVID-19 vaccine can be stored at standard refrigerator temperature

Shot can also be kept at room temperature for 24 hours

- PMLiVE

What Hemingway got right about patient communications

By Andrew Beardshall and Matt Hunt

https://youtu.be/31HPuvXWs0g

Overcoming Behavioral Health Access Limitations Through Telemedicine

Phil Hirsh, PhD, Founder & Chief Executive at Synergia Integrated teleBehavioral Health; and Craig Wright, MD, Senior Physician Executive and Consultant, discuss a range of topics surrounding telemedicine and other digital health...

Impetus Digital

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links